Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

University of British Columbia

$10,000.00

Gynecologic Cancer Impact Accelerator

EF 2023-24

Résumé
Each year, 12,000 Canadian women and gender-diverse people will face the anguish of a new diagnosis of gynaecological cancer (ovarian, endometrial, cervical, vaginal and vulvar) and the toxic side effects of current treatments. Since the start of the new millennium, our team of Canadian researchers have made key discoveries in gynecologic cancer which have led to progressive prevention strategies, precise diagnostic tools and tailored treatment plans. However, these evidence-based interventions are under-utilized, not uniformly available across Canada, and have not been tailored with an equity, diversity and including lens hampering the ability to improve health outcomes for all Canadians. This proposal will focus on two interventions: (1) molecular stratification of endometrial and vulvar cancers to direct care, and (2) genetic testing for the prevention of ovarian and endometrial cancer. A priority for this proposal is to develop knowledge translation strategies that addresses disparities due to race and ethnicity. Our team of gynecologic cancer researchers, clinicians, community and patient partners will form working groups and convene a series of meetings to help inform the development of (1) a toolkit that will enhance the uptake of molecular testings across hospitals/centers in Canada and (2) strategies to promote genetic testing in underserved populations. The overall goal is to increase awareness and use of the existing high-quality molecular classification and genetic testing interventions by health care providers, and patients and families to improve health outcomes for Canadians.
Programme
Planning and Dissemination Grant - Institute Community Support
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
487948
Name
Mcalpine Jessica N
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Health systems / services
Prcname2
Planning and Dissemination Grants
Projecttitle
Gynecologic Cancer Impact Accelerator
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Cancer Care Delivery; Ethnicity; Genetic Testing; Gynecologic Cancer; Health Equity; Knowledge Mobilization; Molecular Classification; Precision Oncology; Prevention; Race
Abstract
Each year, 12,000 Canadian women and gender-diverse people will face the anguish of a new diagnosis of gynaecological cancer (ovarian, endometrial, cervical, vaginal and vulvar) and the toxic side effects of current treatments. Since the start of the new millennium, our team of Canadian researchers have made key discoveries in gynecologic cancer which have led to progressive prevention strategies, precise diagnostic tools and tailored treatment plans. However, these evidence-based interventions are under-utilized, not uniformly available across Canada, and have not been tailored with an equity, diversity and including lens hampering the ability to improve health outcomes for all Canadians. This proposal will focus on two interventions: (1) molecular stratification of endometrial and vulvar cancers to direct care, and (2) genetic testing for the prevention of ovarian and endometrial cancer. A priority for this proposal is to develop knowledge translation strategies that addresses disparities due to race and ethnicity. Our team of gynecologic cancer researchers, clinicians, community and patient partners will form working groups and convene a series of meetings to help inform the development of (1) a toolkit that will enhance the uptake of molecular testings across hospitals/centers in Canada and (2) strategies to promote genetic testing in underserved populations. The overall goal is to increase awareness and use of the existing high-quality molecular classification and genetic testing interventions by health care providers, and patients and families to improve health outcomes for Canadians.
Competitiondate
202307
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mcalpine, Jessica N
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $10,000~ $0~